Impact of Smoking and Primary Tumor Subsite on Recurrence in HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Abstract

Objective

To describe risk of recurrence and recurrence characteristics between ever- and never-smoking patients with human papillomavirus–associated oropharyngeal squamous cell carcinoma (HPV+ OPSCC) when stratified by primary tumor subsite.

Study Design

Retrospective observational study.

Setting

Tertiary care center.

Methods

Retrospective chart review of 171 patients with HPV+ OPSCC with primary treatment between 2008 and 2019. Five-year recurrence-free survival and risk of recurrence were evaluated through Kaplan-Meier curves with log-rank test and Cox proportional hazards models, respectively.

Results

Of 171 patients with HPV+ OPSCC, 81.9% were male, and the average age was 63.9 years. Eighty patients (46.8%) had a smoking history (average, 17.7 pack-years), including 4 current smokers. Recurrence occurred in 31 patients (18.1%), 19 of whom were ever smokers. The recurrence rate for ever smokers with primary base of tongue (BOT) cancer was 41.7%, while 5.1% of never smokers with BOT primaries had recurrence. For primary tonsillar disease, 9.1% of ever smokers had recurrence versus 19.2% of never smokers. Five-year recurrence-free survival for BOT primaries was lower in ever smokers than never smokers (P = .001) but did not differ between ever and never smokers for tonsillar primaries (P = .215). In multivariable analysis across this period, ever-smoking status was associated with higher risk of recurrence than never-smoking status in BOT primaries (adjusted hazard ratio, 7.36; 95% CI, 1.61-33.68; P = .010) but with lower risk of recurrence after tonsillar primaries (adjusted hazard ratio, 0.23; 95% CI, 0.06-0.89; P = .033).

Conclusion

Smoking may uniquely interact with tumor subsites within the oropharynx to influence recurrence risk. Understanding the association between smoking and HPV+ OPSCC recurrence could lead to personalized, evidence-based treatments to improve oncologic outcomes.

Keywords

oncology head and neck cancer OPSCC HPV smoking tobacco

Get full access to this article

View all access options for this article.

References

Roden

Hobelmann

Vimawala

, et al. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus–associated oropharyngeal cancer treated with transoral robotic surgery. Cancer. 2020;126:1873-1887.

Kobayashi

Hisamatsu

Suzui

Hara

Tomita

Miyazaki

. A review of HPV-related head and neck cancer. J Clin Med. 2018;7:241.

Mahal

Catalano

Haddad

, et al. Incidence and demographic burden of HPV-associated oropharyngeal head and neck cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2019;28:1660-1667.

Ang

Harris

Wheeler

, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35.

Hashibe

Brennan

Chuang

, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18:541-550.

Chaturvedi

D’Souza

Gillison

Katki

. Burden of HPV-positive oropharynx cancers among ever and never smokers in the US population. Oral Oncol. 2016;60:61-67.

Haigentz

Jr Suarez

Strojan

, et al. Understanding interactions of smoking on prognosis of HPV-associated oropharyngeal cancers. Adv Ther. 2018;35:255-260.

Grønhøj

Schmidt Jensen

Wagner

, et al. Impact on survival of tobacco smoking for cases with oropharyngeal squamous cell carcinoma and known human papillomavirus and p16-status: a multicenter retrospective study. Oncotarget. 2019;10:4655-4663.

Thompson

LDR

Burchette

Iganej

Bhattasali

. Oropharyngeal squamous cell carcinoma in 390 patients: analysis of clinical and histological criteria which significantly impact outcome. Head Neck Pathol. 2020;14:666-688.

10.

Liu

Talmor

Mi Low

, et al. How does smoking change the clinicopathological characteristics of human papillomavirus–positive oropharyngeal squamous cell carcinoma? One medical center experience. Clin Med Insights Ear Nose Throat. 2018;11:117955061879224.

11.

Mirghani

Leroy

Chekourry

, et al. Smoking impact on HPV driven head and neck cancer’s oncological outcomes? Oral Oncol. 2018;82:131-137.

12.

Maxwell

Kumar

Feng

, et al. Tobacco use in human papillomavirus–positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res. 2010;16:1226-1235.

13.

Xiao

Pham

Ward

, et al. Impact of active smoking on outcomes in HPV+ oropharyngeal cancer. Head Neck. 2020;42:269-280.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB